Gwajin sarrafa bazuwar Pivotal (RCTs) wanda ke ba da izinin amincewa da allurar rigakafin Covid-19 ba a tsara ba, kuma ba a gwada ba idan allurar ta hana yaduwar kwayar cutar ta SARS-CoV-2. Haka kuma gwaje-gwajen ba su gwada ba idan alluran sun rage haɗarin mace-mace. Binciken gwaje-gwajen kashi bakwai na III, gami da na Moderna, Pfizer/BioNTech da alluran AstraZeneca, sun gano ma'auni da aka gwada maganin a kan shi ne kawai. rage haɗarin alamun Covid-19.
Bai kamata a ɓoye game da waɗannan gaskiyar ba, kamar yadda aka tattauna su a watan Agusta 2020 a cikin BMJ (da da British Medical Journal); daya daga cikin tsofaffin mujallun likitanci da aka fi ambata a duniya. Bugu da ƙari, wannan ba labarin keɓe ba ne, kamar yadda babban editan kuma ya ba da nata summary na yanayin gwajin rigakafin, wanda ya tabbata sosai:
"… muna kan hanyar yin alluran rigakafin da ke rage tsananin rashin lafiya maimakon kariya daga kamuwa da cuta [da] samar da rigakafi na ɗan gajeren lokaci,… da kuma lalata amincin jama'a da ɓarnatar da albarkatun duniya ta hanyar rarraba maganin da ba shi da kyau, wannan na iya canza abin da muka fahimci maganin ya zama. BMJ rufe waɗannan fasalulluka na RCTs. Lokacin da jami'an kiwon lafiya Rochelle Walensky, Henry Walke da Anthony Fauci suka yi iƙirari (a cikin Journal of Amirka Medical Association) "Gwajin da likitoci suka yi ya nuna cewa allurar rigakafin da aka ba da izinin amfani da su a Amurka suna da tasiri sosai kan kamuwa da cutar ta Covid-19, rashin lafiya mai tsanani da mutuwa" an ji wannan ƙaryar cewa mujallar ta buga sharhi mai taken "Magana mara inganci. "
Tushen sharhin shine farkon ƙarshen ƙarshen RCTs shine alamun Covid-19; ƙarancin ma'auni fiye da gwaji don nuna inganci akan kamuwa da cuta, rashin lafiya mai tsanani, da mutuwa.
Amma duk da haka waɗannan abubuwan na gwajin rigakafin da aka tattauna a cikin mujallun likitanci ba su da masaniya ga jama'a. Don auna fahimtar jama'a game da gwajin rigakafin Covid-19 na ƙara tambaya game da gwajin rigakafin zuwa binciken wakilan ƙasa da ke gudana na manyan New Zealanders.
Duk da yake ba mai hankali bane ga yawancin masu karatu, New Zealand wuri ne mai fa'ida don ganowa game da fahimtar jama'a game da gwajin rigakafin. Har zuwa kwanan nan, lokacin da aka ba da izinin wasu allurai na AstraZeneca da Novavax, Pfizer 100% ne, yana sauƙaƙa kalmar tambayar binciken musamman game da gwajin rigakafin Pfizer.
Har ila yau, an yi wa 'yan New Zealand allurar rigakafi a cikin ɗan gajeren lokaci, kafin binciken. A ƙarshen Agusta 2021 New Zealand ta kasance ta ƙarshe a cikin OECD a cikin ƙimar alluran rigakafi amma a watan Disamba, lokacin da aka gabatar da binciken, ta tsallake zuwa rabin rabin OECD, tare da haɓakar allurar rigakafi da matsakaicin 110 allurai a cikin 100 mutane a cikin fiye da watanni uku.
Wannan saurin haɓakar rigakafin ya kasance wani ɓangare na umarni, na kiwon lafiya, ilimi, 'yan sanda, da ma'aikatan gaggawa da kuma tsarin fasfo na rigakafi wanda ya toshe waɗanda ba a yi musu allurar ba daga mafi yawan wurare. An yi amfani da umarnin sosai, har ma da mutanen da ke fama da rashin lafiya bayan harbinsu na farko, kamar Bell's Palsy da kuma pericarditis, har yanzu dole ne a sami harbi na biyu. Dokar fasfo din rigakafin ta riga ta wuce Majalisar Dokoki kafin binciken, don haka alluran rigakafin, da abin da ake tsammani daga gare su, yakamata su kasance mafi mahimmanci a cikin zukatan mutane.
Wani abin da ya dace game da New Zealand shine kafofin watsa labarai da gwamnati ke mamaye, wanda ko dai ana ba da tallafin jama'a, ko kuma yana da yawa. tallafi ta hanyar "asusun kula da aikin jarida" da kuma gwamnati mai karimci tallan rigakafin Covid-19. Har ila yau, masu sharhi masu zaman kansu fitattu a kafafen yada labarai sun samu nasu kalmomin magana game da alluran rigakafin daga gwamnati a cikin wani shiri da aka tsara a tsanake na dangantakar jama'a.
Don haka, galibi 'yan jaridun kasashen waje ne suka bayyana hakan damuwa Lokacin da Firayim Minista na New Zealand ya yi da'awar Orwellian cewa a cikin batutuwan Covid-19 da alluran rigakafi: "Karre wani abu, za mu ci gaba da kasancewa tushen gaskiyar ku guda ɗaya."
Duk da haka kafofin watsa labarai da gwamnati ke sarrafawa da kuma tallan rigakafin rigakafi sun ba da gudummawa rashin fahimta ta jama'a game da gwajin allurar rigakafin da aka yi a gwaji mai mahimmanci. Binciken ya tambayi idan an gwada maganin Pfizer akan: (a) hana kamuwa da cuta da yada SARS-CoV-2, ko (b) rage haɗarin kamuwa da alamun Covid-19, ko (c) rage haɗarin kamuwa da rashin lafiya ko mutuwa, ko (d) duk abubuwan da ke sama. Amsar da ta dace ita ce (b), gwaje-gwajen an saita su ne kawai don gwaji idan allurar rigakafin sun rage haɗarin samun alamun Covid-19.
Kashi hudu ne kawai na wadanda suka amsa suka sami amsar da ta dace. A takaice dai, kashi 96 cikin 19 na manya 'yan New Zealand sun yi tunanin an gwada allurar rigakafin Covid-XNUMX akan ƙarin sharuɗɗa masu buƙata fiye da yadda lamarin yake.
A halin yanzu, yawancin shari'o'in Covid-19 a cikin New Zealand allurar riga-kafi ne. Kuma duk da kusan kowa da kowa yana yin rigakafin, kuma mafi yawan haɓakawa, adadin sabbin shari'o'in Covid-19 da aka tabbatar yana ɗaya daga cikin mafi girma a duniya. Kamar yadda mutane ke gani da idanunsu cewa har yanzu mutum na iya kamuwa da cutar za su iya tambayar abin da aka kai su ga (rashin fahimta) game da allurar.
A wani wuri kuma an lura da cewa rigakafin tsatsauran ra'ayi-musamman ƙin rigakafi na halitta - yana haifar da shubuhar allurar. Kamar yadda mutane ke ganin cewa hukumomin kiwon lafiyar jama'a sun yi ƙarya game da rigakafi na halitta za su yi mamakin ko sun yi ƙarya game da ingancin rigakafin. Hakazalika, yayin da suka fahimci cewa an ba su ra'ayi mai ɓarna game da abin da aka gwada magungunan a kan suna iya shakkar wasu da'awar game da rigakafin.
Musamman, ta hanyar yarda cewa an gwada alluran akan ƙarin ma'auni masu buƙata fiye da yadda ake tsammani, tsammanin jama'a na abin da allurar za ta cimma ya yi yawa. Kamar yadda jama'a ke shaida gazawar allurar rigakafi don hana kamuwa da cutar SARS-CoV-2, da kuma a gazawar rage yawan mace-mace, shakka game da waɗannan da sauran alluran rigakafi za su yi girma.
A New Zealand wannan batu ya tsananta da Firayim Minista ya haifar da wani daidaitattun ƙarya tsakanin allurar Covid-19 da rigakafin kyanda. A halin yanzu adadin allurar rigakafin yara (wanda ya haɗa da rigakafin kyanda) na Maori na asali ya ragu. Maki 12 cikin shekaru biyu sannan an yi watsi da allurar rigakafin cutar kyanda miliyan 0.3 bayan karewarsu saboda rashin bukata. Tallace-tallacen allurar rigakafin Covid-19 musamman yana hari kan Maori, tare da iƙirarin cewa masu haɓakawa za su kare su daga Omicron. Ci gaban cututtuka na iya tabbatar da cewa wannan ikirari ba gaskiya ba ne, don haka Maori na iya zama da shakku game da rigakafin nan gaba, har ma da alluran rigakafin da za a iya kwatanta su da 'aminci da inganci.'
Idan 'yan siyasa da ma'aikatan kiwon lafiya sun kasance masu gaskiya ga jama'a, suna fitar da ka'idojin da aka gwada rigakafin Covid-19, da abin da za a iya kuma ba za a iya tsammanin allurar ba, to wannan rashin fahimta ta yadu bai kamata ya faru ba. Maimakon haka, rashin gaskiyarsu na iya yin illa ga yunƙurin rigakafin da za a yi nan gaba da cutar da lafiyar jama’a.
-
John Gibson, Farfesa a fannin tattalin arziki, yana koyarwa a Jami'ar Waikato. Ya taba koyarwa a Jami'ar Canterbury da Kwalejin Williams, ya kasance baƙon bincike a Cibiyar Nazarin Tattalin Arzikin Afirka, Jami'ar Oxford kuma Mataimakin Bincike ne a Cibiyar LICOS don Cibiyoyi da Ayyukan Tattalin Arziki a KU Leuven. Ya sami digirin digirgir a Jami’ar Stanford kuma tun daga nan ya yi aiki a duniya a kasashe irin su Cambodia, China, India, Papua New Guinea, Russia, Samoa, Solomon Islands, Thailand, Tonga, Vanuatu, da Vietnam. Shi ɗan'uwa ne na Royal Society of New Zealand kuma ƙwararren ɗan'uwan New Zealand Association of Economics da na Australasia Agricultural and Resource Economics Society.
Duba dukkan posts
